Medical Blog About Treatment Abroad

Cancer is one of the leading causes of death among humanity, with approximately 20 million new cases each year and 9.7 million cancer deaths worldwide. About 1 in 5 people will develop cancer in their lifetime, making it a global health concern. There are different treatment options available, but no one can guarantee a complete cure.

Immune-based therapy is an innovative method of cancer treatment, and one of the most promising innovations is dendritic cell therapy. This radical approach utilizes the strength of the patient's immune system to attack carcinoma and destroy tumor cells. The 2011 Nobel Prize in Medicine, awarded to Ralph M. Steinman as a discoverer...

One or two decades ago, a cancer diagnosis was almost equated to death. Nowadays, due to the fast development of healthcare, numerous oncological diseases can be cured. Nevertheless, the cancer burden is still high in Europe. The European Cancer Information System (ECIS) states that in 2022 around 4.1 million new cases of cancer were...

A benign brain tumor is a non-cancerous, slow-growing mass of cells in and around the brain tissue. It accounts for nearly 72% of all primary brain neoplasms, with an incidence of roughly 17.69 per 100,000 people. Non-malignant primary central nervous system (CNS) tumors are more frequently diagnosed in females, with research indicating that...

Cervical cancer affects approximately 660,000 women worldwide each year, making it the fourth most common cancer among women globally. While early detection typically offers excellent cure rates, advanced cases require innovative treatment approaches. Dendritic cell therapy represents a promising personalized immunotherapy...

While central nervous system (CNS) disorders are relatively rare, they contribute to substantial morbidity and mortality across all age groups. Despite decades of research into the etiology of pediatric and adult brain tumors, no single risk factor has been identified that accounts for a significant proportion of cases. These tumors are histologically...

Breast cancer immunotherapy (IT) represents a groundbreaking advancement in oncology, encompassing various innovative approaches to breast cancer treatment. Breast cancer (BC, BCa) is one of the most common malignant tumors globally, but here's the thing – it's been considered an immunologically "cold" tumor with way less... 

Living with small intestine cancer can be difficult, but it leaves reason for optimism. Despite the rarity of this disease, more therapeutic options are available today than ever before. With timely and correct treatment, the five-year survival rate in the early stages can exceed 80%, which highlights the importance of specialized care. Surgery...